ASK REDCHAT ANYTHING ABOUT AKEBIA THERAPEUTICS, INC.
Akebia Therapeutics, Inc. (NASDAQ: AKBA)
Listen to this Section
$0.95
-0.0253
(
-2.61% )
1.0M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Auryxia (ferric citrate)DetailsChronic kidney disease, Anemia, Kidney disease, Hyperphosphatemia |
Approved |
| Vafseo™ (Vadadustat)DetailsChronic kidney disease, Anemia, Kidney disease |
Approved |
Market Data
|
| Open |
$0.95 |
| Previous Close |
$0.97 |
| Volume |
1.0M |
| Market Cap |
$260.13M |
| Day Range |
$0.94 - $0.99 |
| 52 Week Range |
$0.88 - $4.08 |
| Shares Outstanding |
268.26M |
| Change % |
-2.61% |
| Net Change |
▼ -0.0253 |
| Insider Ownership |
N/A |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Year | 2014 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-2,547,335.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-07-02 |
Sale |
-350000.00 |
Ostrowski Erik |
| 2024-06-10 |
Sale |
-30000.00 |
ROGERS MICHAEL W |
| 2024-06-10 |
Sale |
-30000.00 |
FRIESON RON |
| 2024-06-10 |
Sale |
-30000.00 |
ZUMWALT LEANNE M |
| 2024-06-10 |
Sale |
-30000.00 |
ADAMS ADRIAN |
| 2024-06-10 |
Sale |
-30000.00 |
GILMAN STEVEN C |
| 2024-06-10 |
Sale |
-30000.00 |
Smith Cynthia |
| 2024-06-10 |
Sale |
-30000.00 |
Wolf Myles |
| 2024-05-14 |
Sale |
-12016.00 |
Hadas Nicole R. |
| 2024-05-14 |
Sale |
-34840.00 |
Dahan Michel |